IRVINE, Calif.--(BUSINESS WIRE)--IDM Pharma, Inc. (Nasdaq: IDMI) today announced that the Company will be presenting at the Sixth Annual JMP Securities Research Conference in San Francisco on Tuesday, May 22, 2007.
Jean-Loup Romet-Lemonne, M.D., Chief Executive Officer of IDM Pharma, will be providing a corporate overview and update on the development status of the Company's product candidates. The presentation is scheduled on Tuesday, May 22, 2007 at 8:00 a.m. PT at The Ritz-Carlton, San Francisco.
